Evidence map›Paper›PMID 30760556›Full record

ArticleLife science alliance2019

An essential role for α4A-tubulin in platelet biogenesis.

Catherine Strassel, Maria M Magiera, Arnaud Dupuis, Morgane Batzenschlager, Agnès Hovasse, Irina Pleines, Paul Guéguen, Anita Eckly, Sylvie Moog, Léa Mallo and 13 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Life science alliance, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 53 citations in OpenAlex.

  1. TUBA4A: The Tale of an Unconventional Tubulin.Cytoskeleton (Hoboken, N.J.) · 2026
    Review
  2. Article
  3. Article
  4. Looking Under the Hood at the Cytoskeletal Engine of Platelet Production.Arteriosclerosis, thrombosis, and vascular biology · 2025
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. MAPping tubulin mutations.Frontiers in cell and developmental biology · 2023
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors at 6 institutions in 2 countries.

Catherine StrasselUniversité de Strasbourg, Institut National de la Santé et de la Recherche Médicale, Etablissement Français du Sang Grand Est, Unité Mixte de Recherche-S 1255, Fédération de Médecine Translationnelle de Strasbourg, Strasbourg, France.
Maria M MagieraInstitut Curie, Paris-Sciences-et-Lettres Research University, CNRS UMR3348, Orsay, France.ORCID 0000-0003-4847-3053
Arnaud DupuisUniversité de Strasbourg, Institut National de la Santé et de la Recherche Médicale, Etablissement Français du Sang Grand Est, Unité Mixte de Recherche-S 1255, Fédération de Médecine Translationnelle de Strasbourg, Strasbourg, France.ORCID 0000-0001-9058-7295
Morgane BatzenschlagerUniversité de Strasbourg, Institut National de la Santé et de la Recherche Médicale, Etablissement Français du Sang Grand Est, Unité Mixte de Recherche-S 1255, Fédération de Médecine Translationnelle de Strasbourg, Strasbourg, France.ORCID 0000-0002-7559-9172
Agnès HovasseLaboratoire de Spectrométrie de Masse BioOrganique, Institut Pluridisciplinaire Hubert Curien, CNRS UMR7178, Université de Strasbourg, Strasbourg, France.
Irina PleinesACRF Australian Cancer Research Foundation Chemical Biology Division, the Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.
Paul GuéguenLaboratoire de génétique moléculaire et d'histocompatibilité, Centre Hospitalier Régional et Universitaire Morvan, INSERM U1078, EFS Bretagne, Brest, France.
Anita EcklyUniversité de Strasbourg, Institut National de la Santé et de la Recherche Médicale, Etablissement Français du Sang Grand Est, Unité Mixte de Recherche-S 1255, Fédération de Médecine Translationnelle de Strasbourg, Strasbourg, France.
Sylvie MoogUniversité de Strasbourg, Institut National de la Santé et de la Recherche Médicale, Etablissement Français du Sang Grand Est, Unité Mixte de Recherche-S 1255, Fédération de Médecine Translationnelle de Strasbourg, Strasbourg, France.
Léa MalloUniversité de Strasbourg, Institut National de la Santé et de la Recherche Médicale, Etablissement Français du Sang Grand Est, Unité Mixte de Recherche-S 1255, Fédération de Médecine Translationnelle de Strasbourg, Strasbourg, France.
Quentin KimmerlinUniversité de Strasbourg, Institut National de la Santé et de la Recherche Médicale, Etablissement Français du Sang Grand Est, Unité Mixte de Recherche-S 1255, Fédération de Médecine Translationnelle de Strasbourg, Strasbourg, France.
Stéphane ChappazACRF Australian Cancer Research Foundation Chemical Biology Division, the Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.
Jean-Marc StrubLaboratoire de Spectrométrie de Masse BioOrganique, Institut Pluridisciplinaire Hubert Curien, CNRS UMR7178, Université de Strasbourg, Strasbourg, France.
Natarajan KathiresanInstitut Curie, Paris-Sciences-et-Lettres Research University, CNRS UMR3348, Orsay, France.
Henri de la SalleUniversité de Strasbourg, Institut National de la Santé et de la Recherche Médicale, Etablissement Français du Sang Grand Est, Unité Mixte de Recherche-S 1255, Fédération de Médecine Translationnelle de Strasbourg, Strasbourg, France.
Alain Van DorsselaerLaboratoire de Spectrométrie de Masse BioOrganique, Institut Pluridisciplinaire Hubert Curien, CNRS UMR7178, Université de Strasbourg, Strasbourg, France.
Claude FerecLaboratoire de génétique moléculaire et d'histocompatibilité, Centre Hospitalier Régional et Universitaire Morvan, INSERM U1078, EFS Bretagne, Brest, France.
Jean-Yves PyEFS Centre-Pays de la Loire, site d'Orléans, France.ORCID 0000-0001-7595-5512
Christian GachetUniversité de Strasbourg, Institut National de la Santé et de la Recherche Médicale, Etablissement Français du Sang Grand Est, Unité Mixte de Recherche-S 1255, Fédération de Médecine Translationnelle de Strasbourg, Strasbourg, France.
Christine Schaeffer-ReissLaboratoire de Spectrométrie de Masse BioOrganique, Institut Pluridisciplinaire Hubert Curien, CNRS UMR7178, Université de Strasbourg, Strasbourg, France.
Benjamin T KileACRF Australian Cancer Research Foundation Chemical Biology Division, the Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.
Carsten JankeInstitut Curie, Paris-Sciences-et-Lettres Research University, CNRS UMR3348, Orsay, France Carsten.Janke@curie.fr.ORCID 0000-0001-7053-2000
François LanzaUniversité de Strasbourg, Institut National de la Santé et de la Recherche Médicale, Etablissement Français du Sang Grand Est, Unité Mixte de Recherche-S 1255, Fédération de Médecine Translationnelle de Strasbourg, Strasbourg, France francois.lanza@efs.sante.fr.ORCID 0000-0002-5802-4748
Établissement Français du Sang · FRCentre National de la Recherche Scientifique · FRUniversité Paris-Sud · FRWalter and Eliza Hall Institute of Medical Research · AUInserm · FRCentre Pays de la Loire · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During platelet biogenesis, microtubules (MTs) are arranged into submembranous structures (the marginal band) that encircle the cell in a single plane. This unique MT array has no equivalent in any other mammalian cell, and the mechanisms responsible for this particular mode of assembly are not fully understood. One possibility is that platelet MTs are composed of a particular set of tubulin isotypes that carry specific posttranslational modifications. Although β1-tubulin is known to be essential, no equivalent roles of α-tubulin isotypes in platelet formation or function have so far been reported. Here, we identify α4A-tubulin as a predominant α-tubulin isotype in platelets. Similar to β1-tubulin, α4A-tubulin expression is up-regulated during the late stages of megakaryocyte differentiation. Missense mutations in the α4A-tubulin gene cause macrothrombocytopenia in mice and humans. Defects in α4A-tubulin lead to changes in tubulin tyrosination status of the platelet tubulin pool. Ultrastructural defects include reduced numbers and misarranged MT coils in the platelet marginal band. We further observed defects in megakaryocyte maturation and proplatelet formation in

Indexed as

Alkylating AgentsAnimalsAntigens, CD34Blood PlateletsCells, CulturedEthylnitrosoureaHumansMaleMegakaryocytesMiceMice, Inbred BALB CMicrotubulesMutation, MissensePlatelet CountThrombocytopeniaThrombopoiesisAlkylating AgentsAntigens, CD34EthylnitrosoureaTubulin

Identifiers

PMID30760556
PMCPMC6374996
OpenAlexW2914453787

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.